Topic

Enhertu (fam-trastuzumab deruxtecan-nxki)

A collection of 38 issues

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Aetna CVS Health in Washington: Complete PA Guide and Appeals Process

Answer Box: Getting Enhertu Covered in Washington Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved indications. Approval requires documented HER2 status (IHC 3+, ISH+, HER2-low 1-2+, or HER2-mutant), prior therapy failure, board-certified oncologist prescriber, and ILD monitoring plan. Submit via Aetna Enhertu Precertification Form GR-69531
5 min read

How to Get Enhertu Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization Guide with Appeals Process

Answer Box: Getting Enhertu Covered by Aetna CVS Health in Pennsylvania Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved cancer indications. Your oncologist must submit documentation proving HER2-positive, HER2-low, or HER2-mutant status plus evidence of prior therapy failures. The fastest path: gather HER2 testing results
6 min read

Do You Qualify for Enhertu Coverage by UnitedHealthcare in Washington? Decision Tree & Next Steps

Answer Box UnitedHealthcare requires prior authorization (PA) for Enhertu (fam-trastuzumab deruxtecan-nxki) in Washington, mandating HER2-positive biomarker testing, specific cancer diagnoses, and evidence of prior HER2-targeted therapy failure. Submit PA via the UnitedHealthcare Provider Portal with pathology reports, treatment history, and oncologist letter. If denied, Washington residents can appeal internally (60
5 min read

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Aetna CVS Health in Florida: Complete Prior Authorization Guide and Appeals Process

Answer Box: Getting Enhertu Covered by Aetna CVS Health in Florida Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved indications. The fastest path to approval: (1) Submit Aetna's Enhertu precertification form (GR-69531 5-24) with HER2 testing results and prior therapy documentation, (2) Include
6 min read

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Enhertu Covered by BCBS in New York Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Blue Cross Blue Shield plans in New York for HER2-positive breast cancer, NSCLC, and gastric cancer. Key requirements include documented HER2 status (IHC 3+ or ISH amplified), prior trastuzumab-based therapy failure, and NCCN
6 min read

The Requirements Checklist to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Blue Cross Blue Shield in New Jersey: Forms, Appeals, and PA Guide

Answer Box: Getting Enhertu Covered by Blue Cross Blue Shield in New Jersey Eligibility: HER2-positive unresectable/metastatic breast cancer or other FDA-approved HER2-expressing tumors after prior anti-HER2 therapy. Fastest path: Submit prior authorization via Horizon BCBS Provider Portal or MagellanRx (1-800-424-4508) with HER2 pathology report, treatment history, and monitoring plan.
5 min read